Mark Woodward's Publications

About Mark Woodward's Publications

Senior Professorial Fellow, Professorial Unit
  • Chair of Statistics, Epidemiology and Women’s Health at Imperial College London
  • Professor of Medical Statistics, Faculty of Medicine, UNSW Sydney
  • PhD ,
  • FMedSci,
  • FAHMS,
  • FESC

  • Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis

    The Lancet Date published:

  • A Location-Scale Joint Model for Studying the Link Between the Time-Dependent Subject-Specific Variability of Blood Pressure and Competing Events

    Statistics in Medicine Date published:

  • First trimester maternal infections and offspring congenital heart defects: a meta-analysis

    European Heart Journal Date published:

  • International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL

    Diabetes Care Date published:

  • Lipoprotein levels and statin treatment related to dementia and cognitive decline in individuals with type 2 diabetes: an observational analysis from the ADVANCE study

    Cardiovascular Diabetology Date published:

  • A Process Evaluation of a Cluster Randomised Trial in Women’s Cardiovascular Prevention Hosted in Hairdressing Salons

    Heart, Lung and Circulation Date published:

  • Sex Differences Across Corticosteroid Response and Outcomes in IgA Nephropathy

    Kidney International Reports Date published:

  • Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobank

    BMC Gastroenterology Date published:

  • Extrahepatic disease clusters and mortality in people with steatotic liver diseases: a prospective analysis of 64,749 females and 113,587 males in the UK Biobank

    BMC Medicine Date published:

  • Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset

    Diabetes, Obesity and Metabolism Date published:

  • Statistical analysis plan for the STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER) study: a randomised, open label, controlled trial in subjects with persistent neurological symptoms after COVID-19 infection

    Unknown Date published:

  • Development and calibration of the 2023 Australian cardiovascular disease risk prediction equations: a model updating study

    Medical Journal of Australia Date published:

  • Reproductive factors and the risk of incident peripheral arterial disease hospitalization or death: a cohort study of UK Biobank participants

    American Journal of Obstetrics and Gynecology Date published:

  • Distribution of cardiovascular disease risk based on the updated 2023 guideline-recommended Australian cardiovascular disease risk algorithm and comparison with the 2012 algorithm

    Unknown Date published:

  • Obesity drives the link between liver fat and depression: Cross-sectional and prospective investigations

    Diabetes, Obesity and Metabolism Date published:

  • 418-P: Impact of Intensive Lifestyle Intervention on Kidney Disease Progression in People with Type 2 Diabetes-The Look AHEAD Study

    Diabetes Date published: